Diffusion tensor magnetic resonance imaging (DTI) has the unique ability to resolve 3D tissue microstructure in intact organs. 9, 10 In the myocardium, however, DTI is extremely challenging to perform because of the motion of the heart. [11] [12] [13] Consequently, although numerous valuable studies have been performed ex vivo, [4][5][6][7] [14] [15] [16] [17] [18] 
M yocardial regeneration remains one of the central goals of cardiovascular research. 1 The myocardium, however, has a complex 3-dimensional (3D) microstructure. Fibers in the subendocardium and subepicardium form an array of crossing helices, whereas those in the midmyocardium are circumferential. 2, 3 This 3D architecture plays a crucial role in the mechanical function of the heart and is perturbed in a range of diseases including myocardial infarction and heart failure. [4] [5] [6] [7] The regeneration of functional myocardium thus requires not only the ability to generate functional cardiomyocytes but also the ability to restore normal 3D myofiber architecture. New techniques to better characterize the microstructural impact of ischemia as well as the ability of injected cells to restore normal 3D myofiber architecture are therefore sorely needed. 8 
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April 29, 2014 have been performed. 12, 13, [19] [20] [21] [22] Moreover, these in vivo studies have been limited to 2-dimensional (2D) measures of myocardial microstructure 23 or have involved 3D tractography in healthy human volunteers. 24 In the present report, we present the ability to perform DTI tractography of the mouse heart in vivo. The technique is used to image mice after coronary ligation and cell injection and is validated by comparison with ex vivo imaging and histology. To the best of our knowledge, this study involves the first use of 3D tractography to study ischemic myocardium in vivo, the first use of DTI or tractography to assess the impact of cell therapy in the heart, and the first demonstration of DTI in the mouse heart in vivo.
Methods
All procedures were performed in accordance with an approved research protocol at our institution. Additional details and a selected list of abbreviations are provided in Methods in the online-only Data Supplement.
In Vivo DTI and Tractography
A motion-compensated version of the Stejskal-Tanner diffusion sequence was implemented to perform DTI tractography of the mouse heart in vivo. 13 Rather than the monopolar gradients used in conventional brain DTI sequences, a pair of bipolar diffusion-encoding gradients was used ( Figure 1A and 1B ). Validation and testing of the approach were performed in healthy C57BL6 mice (n=6). Imaging was performed on a 9.4-T horizontal-bore scanner (Biospec, Bruker, Billerica, MA) with a 1500-mT/m gradient insert (Resonance Research, Billerica, MA).
Three-dimensional DTI of the heart was performed with ECG and respiratory gating (SA Instruments, Stonybrook, NY) with the use of a fat-suppressed single-shot spin echo sequence with an echoplanar imaging readout. First-order motion-compensated, diffusion-encoding gradients were placed on both sides of the 180° refocusing pulse ( Figure 1B ). Typical sequence parameters included the following: field of view 20×20×8 mm 3 , matrix 70×70×28 interpolated to 128×128×51, resolution 156 μm (isotropic), repetition time 1000 ms, echo time 14 ms, b-value of 500 to 650 s/mm 2 , 24 diffusion-encoding directions plus 1 b0 (no diffusion encoding) image, and 2 averages. Scan duration was ≈35 minutes.
In each animal, 2D DTI was also performed to compute mean diffusivity (MD) and fractional anisotropy (FA) maps. Three 2D slices were acquired in the short axis from the mid left ventricle (LV) to the apex. Parameters included the following: field of view 20×20 mm 2 , slice thickness 1 mm, matrix 70×70 interpolated to 128×128, in-plane resolution 156×156 μm 2 , repetition time 2000 ms, echo time 14 ms, b-value of 500 to 650 s/mm 2 , 6 diffusion-encoding directions plus 1 b0 image, and 16 averages.
Image analysis was performed with the use of software developed in our center. In each voxel, diagonalization of the diffusion tensor was performed to yield its eigenvectors and eigenvalues. Two-dimensional maps of MD and FA were computed as described previously. 5 Twodimensional maps of fiber helix angle (HA) were created by projecting the primary eigenvector onto the radial plane of the LV. 3 In addition, the diffusion tensor field was modeled with the use of superquadric glyphs, 14 in which the orientation and color of the glyphs reflected HA and their shape was determined by the diffusion eigenvalues.
Tractography was performed by numerically integrating the primary eigenvector fields into coherent streamlines. To standardize the analysis, only those tracts intersecting a cuboid region of interest (ROI), placed in the lateral wall of the mid LV, were displayed and evaluated. The dimensions and location of the ROI were kept constant in all of the mice imaged in the study. Tract length was limited to half the circumference of the LV to aid visualization. A propagation angle >35° was a criterion for tract termination. The resolved tracts were color-coded by HA at each point along the tract. Histograms of tract HA were constructed by assigning a single HA value to the tract on the basis of the HA at its midpoint. The HA range was defined by the furthest points in the histogram with an amplitude >10% of the maximum amplitude.
Diffusion Spectrum Imaging Tractography
Diffusion spectrum imaging (DSI) tractography of normal mouse hearts (n=5) was performed ex vivo. The excised hearts were immersed in a fluorocarbon magnetic susceptibility-matching medium (Fomblin, Ausimont, NJ) and imaged with a 3D diffusion-encoded Figure 1 . In vivo diffusion tensor magnetic resonance imaging of the mouse heart with motioncompensated diffusion-encoding gradients. A, Classic Stejskal-Tanner spin echo sequence with monopolar diffusion-encoding gradients on either side of the 180 o refocusing pulse. B, Motioncompensated sequence with velocity-compensated bipolar diffusion-encoding gradients. A trigger delay (TD) is applied to acquire the images in midsystole. EPI indicates echoplanar imaging. C and D, Diffusion-encoded images of a normal mouse in vivo with the uncompensated (Uncomp.) sequence (C) and the motion-compensated (Comp.) sequence (D). Severe image degradation is present in the uncompensated sequence, whereas image quality in the motion-compensated sequence is high. E and F, Diffusion tensor magnetic resonance imaging with the velocity-compensated sequence at different phases of the cardiac cycle. Velocity compensation is inadequate at phases of the cardiac cycle with a high proportion of higher-order motion coefficients (E) but works robustly in midsystole (F). G, Twodimensional helix angle map in a normal mouse in vivo. The expected transmural gradient in helix angle in the left ventricle is well seen. H, Diffusion tensor field in the left ventricle, represented by superquadric glyphs and color-coded by helix angle, demonstrating that the anisotropic nature of the myocardium has been accurately resolved with in vivo diffusion tensor magnetic resonance imaging. Stejkal-Tanner sequence. The field of view (10.5-14 mm) 2 , matrix (96-128), and image parameters were adjusted in each heart to minimize N/2 ghosts and optimize signal-to-noise ratio. Typical parameters included the following: spatial resolution 110 μm (isotropic), repetition time 700 to 1200 ms, echo time 18 to 20 ms, b-value of 5000 to 10000 s/mm 2 , 514 diffusion-encoding directions plus 1 b=0 s/mm 2 image, and 1 to 2 averages.
Tractography of the DSI data sets was performed as described previously. 6, 9 The size and location of the ROI used to analyze the tracts were identical to those used for the in vivo DTI data. Likewise, HA histograms of fibers passing through the ROI were derived and analyzed in an identical manner for both the DSI and DTI data sets.
In Vivo DTI Tractography in Ischemic Injury
In vivo DTI tractography was performed in mice with acute myocardial infarction (n=6) and ischemia/reperfusion (IR; n=12) 24 hours after coronary ligation. In addition, ex vivo DTI tractography was performed in a separate cohort of mice (n=6) 3 weeks after myocardial infarction. In all mice, ligation of the left coronary artery was performed to injure the anterior and lateral walls of the LV. In the IR group, the ligation was released after 30 minutes.
In the acutely infarcted mice, in vivo MD maps and T2-weighted MRI were used to delineate the area at risk (AAR), 25 and late gadolinium enhancement was performed to assess myocardial viability. After MRI, ex vivo measurements of the AAR and infarct size were made with the use of fluorescent microspheres and tetrazolium chloride. The impact of myocardial edema on DTI tractography was assessed by serial in vivo imaging of the mice with IR 24 hours and 3 weeks after injury. At the 3-week time point, the mice in the IR group entered the cell therapy arm of the study.
DTI Tractography of Cell Therapy
The impact of cell therapy was assessed with serial in vivo imaging in 2 groups of mice. Group 1 (n=6) consisted of donor FVB and recipient C57BL6 mice and was designed to assess the ability of DTI tractography to detect a potentially deleterious response. Group 2 (n=6) consisted of C57BL6 donor and C57BL6 recipient mice. In both groups, 10 5 bone marrow mononuclear cells (BMMCs) were harvested from the donor mice and injected directly into the myocardium of the recipient mice 3 weeks after IR.
The BMMCs were isolated from the femurs of the donor mice. The marrow was flushed with sterile saline and passed through a 70-μm filter to remove debris. The filtrate was centrifuged at 1600 rpm for 10 minutes, and the pellet was suspended in minimum essential medium Eagle-α modification with 20% fetal bovine serum. The concentration of BMMCs was counted manually with a hemocytometer, and 10 5 BMMCs were resuspended in 12 μL of minimum essential medium Eagle-α modification with 20% bovine serum and 10% Matrigel. The cells were maintained on ice and then injected in 2 passes (6 μL each) into the anterolateral wall of the LV at the border of the normal and injured myocardium.
The recipient mice (C57BL6; 3 weeks after IR; n=12) were imaged with in vivo DTI tractography 1 day before injection and then on days 3, 7, and 10 after BMMC injection. The mice were then euthanized, and the hearts were fixed, sectioned in their short axis in 8-μm-thick sections, and stained with Masson's trichrome. BMMC injection was performed in a third group of mice to assess cell survival. The cells were harvested from a line of luciferase-expressing transgenic mice (L2G), courtesy of Dr Ronglih Liao. The BMMCs from these mice were prepared as described above and injected into mice of the same strain (FVB; n=6) 3 weeks after IR. Serial bioluminescence imaging was performed to assess cell survival.
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DTI in Normal Human Volunteers
Normal volunteers were imaged on a 3-T clinical system (Achieva, Phillips, Best, Netherlands) with a maximum gradient strength of 80 mT/m per axis. A motion-compensated 2D diffusion-encoded, single shot, spin echo echoplanar imaging sequence, identical to the sequence used to image the mice, was used. Data acquisition was ECG triggered and performed in midsystole during free breathing with the use of a respiratory gating navigator. Imaging parameters were as follows: field of view 230×104 mm 2 , slice thickness 4 mm (reconstructed to 6 mm), matrix 115×52, in-plane resolution 2×2 mm 2 (reconstructed to 1.4×1.4 mm) 2 , number of slices 7, repetition time 1 RR interval, echo time 58 ms, b-value 500 s/mm 2 , 18 diffusion-encoding directions plus 1 b=0 s/mm 2 image, and 15 averages. Analysis of the human DTI data sets was performed with software developed in our center. The diffusion-weighted images were spatially registered, and the dyadic diffusion tensor was calculated in each voxel. Numeric integration of the primary eigenvector field into diffusion streamlines was performed with the use of a fourth-order Runge-Kutta approach. A propagation angle >35° served as a criterion for tract termination.
Statistical Methods
Comparison of the HA slope and histogram values between DTI and DSI tractography was performed with an unpaired t test. Comparison of the healing scores in the BL6-BL6 and FVB-BL6 mice was performed with a Mann-Whitney test. The correlation between AAR by MD and T2-weighted MRI was performed with Pearson correlation. Comparison of MD and FA values in control mice, mice 24 hours after IR, and mice 3 weeks after IR was performed with ANOVA with a Tukey posttest comparison. Likewise, ANOVA with a Tukey posttest comparison was used to compare serial MD and FA values before and after BMMC implantation. Gaussian data are reported as mean±SD. Nongaussian data are reported as median values with the interquartile range in parenthesis. Transmural HA plots are of mean±SD values at each point. Bar graphs are of mean±SE values.
Results

Accuracy of In Vivo DTI Tractography in Mice
Diffusion encoding with the conventional Stejskal-Tanner sequence produced severe signal degradation of the moving heart ( Figure 1C ). In contrast, image quality with the motion-compensated version of the Stejskal-Tanner sequence was routinely high ( Figure 1D ). As predicted by Gamper and colleagues, 13 image quality was highest when the data were acquired in midsystole ( Figure 1E and 1F) .
In all mice, the transmural evolution of myofiber orientation was robustly resolved with in vivo DTI tractography. This is shown in Figure 2A with the heart viewed from its lateral wall and in Figure 2B with the same heart viewed from its base. Myofibers in the subendocardium have a positive HA (pink/dark blue), those in the subepicardium have a negative HA (yellow/green), and fibers in the midmyocardium are circumferential (cyan). In Figure 2C , small ROIs have been placed in the subepicardium and subendocardium, allowing the crossing helical fiber pattern in the heart to be perceived easily.
A high degree of concordance was seen between myofiber architecture with in vivo DTI tractography ( 
DTI Tractography in Myocardial Infarction
Signal intensity in the T2-weighted images was significantly elevated in the AAR 24 hours after myocardial infarction ( Figure 3A through 3C ). Likewise, a corresponding increase in MD ( Figure 3D ) was seen in the AAR ( Figure 3E ). A strong correlation was seen between the AAR measured by MD elevation and the AAR defined by T2-weighted MRI (R 2 =0.88).
Fiber architecture in the uninjured septum ( Figure 4A ) was normal in the infarcted mice. In contrast, in most cases a profound loss of fiber tracts ( Figure 4B ) was seen in the AAR. Late gadolinium enhancement and tetrazolium chloride staining ( Figure 4C through 4F), however, showed that tract coherence was lost in both nonviable myocardium and viable areas with large local elevations in MD ( Figure 4G through 4K). In the mice imaged 3 weeks after infarction, a profound loss of fiber tracts was seen ( Figure 4L ). The presence of collagen fibers in the healed infarct scar thus did not restrict diffusion adequately to produce tracts resolvable with DTI.
DTI Tractography in IR
In normal mice ( Figure 5A ), MD in the myocardium was fairly uniform and averaged 1.20±0.06×10 ˗3 mm 2 /s. In the mice imaged 24 hours after IR ( Figure 5B ), MD was significantly elevated in the territory of the occluded left coronary artery (1.27±0.06×10 ˗3 mm 2 /s; P<0.05 versus control). However, when imaged 3 weeks later, MD in these mice ( Figure 5C and 5D) had returned almost fully back to baseline (1.22±0.04×10 ˗3 mm 2 /s). As shown in Figure 5E , a corresponding decrease in FA was seen at 24 hours (0.25±0.03 versus 0.29±0.02 in controls; P<0.05), which likewise resolved by 3 weeks (0.29±0.04 versus 0.25±0.03 at 24 hours; P<0.05). Acute myocardial injury was thus characterized by an increase in MD and a decrease in FA.
Fiber architecture in the mice with IR remained highly abnormal at 3 weeks ( Figure 5F ) but was more preserved than in the infarcted mice ( Figure 4L ). Marked differences, however, were seen between tractography in these mice 24 hours and 3 weeks after IR. At the 24-hour time point, a profound loss of tracts was seen, particularly in the subendocardium. However, 3 weeks after IR, the loss of tracts was less pronounced. This is well demonstrated in Figure 5G and 5H, in which serial tractography in a mouse with IR shows a marked recovery of subendocardial fiber tracts (pink/dark blue) between the 24-hour and 3-week time points. The resolution of edema in IR was thus characterized by a reduction in MD, an increase in FA, and an increase in the number of coherent fiber tracts.
DTI Tractography of Cell Therapy
In the BL6-BL6 group, a small (nonsignificant) reduction in MD and increase in FA were seen on day 3 after cell injection Figure 6A ). However, the converse response (increased MD, reduced FA) was seen in both groups of mice at day 7 ( Figure 6B and Table I in the online-only Data Supplement). In a given mouse, accelerated healing in response to cell injection was defined by a sustained decrease in MD, a sustained increase in FA, and the appearance of new myofiber tracts with the correct orientation. Increased MD, reduced FA, and the loss of myofiber tracts defined an impaired healing response (see the online-only Data Supplement). In the BL6-BL6 group, a neutral response to BMCC injection was seen in 4 of 6 mice, accelerated healing in 1 of 6, and impaired healing in 1 of 6 ( Figure 6C ). In the FVB-BL6 group, a neutral response was seen in 5 of 6 mice and impaired healing in 1 of 6. None of the mice in the FVB-BL6 group showed accelerated healing. A scoring system (accel-erated=2, neutral=1, impaired=0) was used to compare the FVB-BL6 and BL6-BL6 groups ( Figure 6D ) and showed no significant differences between the 2 groups (mean score, 0.83±0.41 in FVB-BL6 and 1.00±0.63 in BL6-BL6; P=0.6; median score, 1.0 [0.5 to 1.0] in FVB-BL6 and 1.0 [0.5 to 1.5] in BL6-BL6; P=0. 7) .
DTI tractography of a mouse with a neutral response to BMMC injection is shown in Figure 6E . The loss of myofibers in the apical half of the LV remained extremely profound despite the injection of BMMCs over 7 days before. This was confirmed by HA maps, HA plots, and histology ( Figure 6F through 6J) . Strong agreement was observed in all mice between the in vivo DTI tractography findings and histology. Bioluminescence imaging ( Figure 6K and 6L) showed that the survival of BMMCs injected 3 weeks after IR was high (82.0±15.9% at 13 days) and could not account for the low healing scores.
DTI tractography of the 2 mice in the BL6-BL6 group with a nonneutral response to BMMC injection is shown in Figure 7 . In 1 of the mice (Figure 7A through 7C) , the injected cells produced a decrease in MD and an increase in FA consistent with accelerated healing. Serial tractography in this mouse ( Figure 7A and 7B) showed a profound increase in the number Figure 7D and 7F) , the MD and FA values suggested impaired healing after BMMC injection. Tractography in this mouse revealed a profound loss of subepicardial myofibers and a reduction in the number of subendocardial fibers after cell injection ( Figure 7D and 7E) . Histology on day 10 ( Figures 7C and 7F) confirmed the in vivo tractography findings. HA maps and transmural HA plots ( Figure 7G through 7I) were consistent with the tractography findings in all cases.
DTI Tractography of the Human Heart In Vivo
Tractography of a human volunteer, imaged with a true resolution of 2×2×4 mm 3 , is shown in Figure 8 . The expected transmural evolution in tract HA can be well resolved. Fibers in the subepicardium have a highly negative HA (yellow/red), and those in the subendocardium (dark blue) have a highly positive HA. The tracts are correctly oriented and highly coherent except over the papillary muscles, where a high degree of HA dispersion is a normal finding. Tracts intersecting a transmural ROI Figure 8C . The tracts are highly organized and clearly demonstrate the crossing pattern of myofiber tracts in the subepicardium and subendocardium.
Discussion
The arrangement of myofibers in the heart has a major impact on its mechanical and electric function. 7, 26 Current techniques to characterize 3D myofiber architecture, however, have been limited largely to ex vivo application. 9, 10 In this report, for the first time, we show that DTI and tractography of the mouse heart can be performed successfully in vivo. We further show, for the first time, that serial DTI tractography of the heart in vivo can be used to characterize the response of the myocardium to injury and to assess the ability of injected cells to regenerate new myocardium. A novel approach that advances the understanding of cardiovascular disease and has the potential to guide the development of regenerative therapies in the heart is thus presented.
DTI tractography in the heart is extremely challenging because its bulk motion is 4 to 5 orders of magnitude greater than the mean displacement of water molecules from selfdiffusion. This is particularly the case in mouse hearts, which beat up to 600 times per minute and require a high spatial resolution. In the present study, by using an ultrahigh (1500 mT/m) gradient insert and a motion-compensated version of the Stejskal-Tanner spin echo diffusion sequence, 13 we were able to successfully perform DTI of the mouse heart in vivo. Furthermore, we were able to perform 3D DTI tractography of the entire heart in vivo with isotropic spatial resolution. This has hitherto not been achieved in any mammalian species, in which only highly anisotropic imaging of a portion of the heart has been feasible. [19] [20] [21] These technical advances allowed the microstructure of the heart to be robustly imaged and important insights to be gained into the nature of myocardial injury and regeneration. 
DTI Tractography and Assessment of Myocardial Regeneration
Efforts to regenerate the myocardium have generally been evaluated by the changes they produce in LV volume, ejection fraction, and late gadolinium enhancement. 8 Although of considerable value, these measures are indirect indicators of myocardial regeneration and can be affected by loading conditions and the integrity of the microvascular network. DTI tractography, in contrast, provides a direct readout of myofiber organization and architecture. The technique allows the generation of new myofibers to be detected, characterized, and followed over time. DTI tractography can assess the ability of newly generated cardiomyocytes to assume the correct 3D orientation and integrate appropriately with other myofibers in the heart. The technique thus assays the ability of a given therapy to regenerate organized and functional myocardium and not simply isolated new cardiomyocytes.
The optimal cell type for cardiac regeneration continues to be actively debated. 1, 27 27, 28 The results of our study, however, suggest that BMMCs may not be the optimal cell to regenerate new myocardium. Only 1 mouse injected with BMMCs showed evidence of accelerated healing and myocardial regeneration. In addition, no significant differences were seen between the BL6-BL6 group and the control FVB-BL6 group. These data are consistent with the results of the TIME, Late-Time, and FOCUS trials, in which the injection of BMMCs showed no benefit. 27, 28 DTI tractography may thus provide a uniquely powerful tool to assess the efficacy of novel stem/progenitor cells in preclinical models and subsequently in clinical trials.
Role of DTI Tractography in Ischemic Injury
DTI tractography could play a valuable role in the assessment of myocardial viability, particularly in those in whom gadolinium is contraindicated. Prior studies of DTI in subacute infarction have shown increased dispersion 4 and significant reorientation 21 of fiber architecture in the infarct zone. The interpretation of DTI tractography during the first 24 hours after acute injury, however, is complex. The presence of coherent tracts is highly suggestive of persistent myocardial viability. However, slow disintegration and removal of injured cardiomyocytes, which may take >24 hours in acute infarction, 29 can mask the presence of injury. Imaging 48 to 72 hours after injury overcomes this limitation. The use of a lower tract termination angle would likely also increase the sensitivity to injury but could reduce the ability to resolve residual, damaged, and regenerated myofibers in the infarct and border zone. Further study of this parameter will thus be needed.
The loss of tract coherence in acute injury can be seen in nonviable myocardium as well as viable myocardium with high levels of edema. Myocardial edema, however, resolves within 2 to 3 weeks of injury, at which time DTI tractography provides an accurate and specific readout of microstructural damage in the heart. DTI tractography 3 weeks after injury can thus be used to assess the impact of novel cardioprotective therapies. In the chronic setting (>3 weeks after injury), stable maps of myocardial microstructure can be obtained both before and after the initiation of therapy. Mice in this study were injected with BMMCs 3 weeks after IR for this reason.
Clinical Translation and Conclusion
DTI tractography provides an integrated and comprehensive assessment of 3D microstructure. The optimal reconstruction of 3D data sets, however, requires isotropic spatial resolution. This has not been achieved hitherto with in vivo tractography of the heart but was achieved in the murine arm of this study. In contrast, in vivo DTI of the human heart has been performed to date with highly anisotropic resolution and covering only a small portion of the heart. [19] [20] [21] In the present study, we demonstrate that a gradient system providing 80 mT/m per axis allows DTI tractography in humans to be performed with near-isotropic whole heart coverage. The matrix used to image the volunteers in our study produced a true resolution of 2×2×4 mm 3 , which results in a signal-to-noise ratio very similar to an isotropic resolution of 2.5 mm. In addition, ongoing improvements in gradient strength, shimming, and spatiotemporal image registration will likely result in significantly improved image quality in the near future.
In conclusion, we present an innovative approach, using DTI tractography of the mouse heart in vivo, to assess the degree of microstructural alteration in the myocardium in response to ischemia and cell therapy. The MRI-based tractography approach we describe is fully translatable and does not require the injection of contrast agents or radioactive tracers. DTI tractography has the potential to become a valuable tool in both the clinical and preclinical settings and to provide important insights into the pathogenesis and treatment of a broad range of cardiovascular diseases. 
SUPPLEMENTAL MATERIAL
Methods Supplement
Ex Vivo DSI-Tractography:
Image parameters for the diffusion spectrum imaging (DSI) acquisitions are provided in the main text. In each voxel, Fourier transformation of the diffusion or q-space data produced a 3D probability density function (PDF) of fiber orientation in that voxel. The PDF was converted into an orientation density function (ODF), the maxima of which defined the vector field. 1, 2 Integration of the ODF vector field into streamlines was performed with a 2 nd order Runge-Kutta approach using an angle of 35 o as a termination criterion. The size and location of the region-of-interest (ROI) used to analyze the tracts was identical to that used for the in vivo diffusion tensor MRI (DTI) data.
Evaluation of Area-at-Risk and Myocardial Viability:
In vivo assessment of the area-at-risk (AAR) was performed using a T2-weighted (T2prepared) gradient echo sequence. 3 Myocardial viability was assessed using late gadolinium enhancement (LGE). Both sequences were performed with cardiac and respiratory gating (SA Instruments, Stonybrook NY) and a trigger delay of 40ms to image in late systole. Three slices were acquired in the short axis of the LV from the midventricular level to the apex, corresponding to the zone of injury. The slice locations were identical to those used for 2D DTI. Image parameters for the T2-weighted gradient echo were as follows: FOV 20x20mm 2 , matrix 96x96, slice thickness 1mm, flip angle train MLEV pulse, and was 26ms long. The AAR in both the T2-prepared images and the in vivo MD maps was measured by manual planimetry and expressed as a percent of the LV myocardium in the 3 slices imaged.
LGE was performed 10-20 minutes after the injection of 0.2 mmol/kg of Gd-DTPA using an inversion recovery gradient echo sequence. Image parameters were as follows: FOV 25x25mm 2 , matrix 160 x160, slice thickness 1mm, flip angle 60 o , TR 1000ms, TE 1.4ms, 2 averages. A nonselective adiabatic inversion prepulse was used. The inversion time (600 ms at default) was adjusted to null the uninjured septum.
The AAR ex vivo was measured using fluorescent microspheres (Life Technologies, Carlsbad CA). [4] [5] [6] [7] The microspheres, 10 µm in diameter, were suspended in 100 µl of saline and given by direct injection into the left ventricle 5 min prior to euthanasia. The aortic root was clamped during the microsphere injection, which was performed with the mice ventilated and with the heart exposed via a thoracotomy. The hearts were then excised and sectioned in their short axis into 1mm thick sections using an automated tissue slicer (McIllwain Tissue Chopper, Vibratome, Bannockburn, IL). The thickness of the sections was identical to the T2-weighted MR images (1mm) and co-registration was performed by distance from the atrioventricular groove. Fluorescence reflectance imaging of the sections was performed on a Nikon Eclipse TS100 fluorescent microscope (Nikon, Tokyo, Japan). 6, 7 The area-at-risk was defined by the absence of fluorescence punctates and was manually traced by an investigator blinded to the MRI data. days 0, 1, 4, 6, 8, 11 and 13 post cell injection. The data were normalized to the signal on day 0 and expressed as percent survival.
Results Supplement
The % change (Δ) in MD and FA after BMMC injection was calculated using the preinjection values as the baseline reference. Comparison across both groups of mice at all time points was performed with ANOVA and a Tukey's post-test (see main text). No significant differences in ΔMD or ΔFA were seen at any time point either within the BL6-BL6 and FVB-BL6 groups, or between them. 
